Skip to main content
. 2021 Jun 18;12(7):2007–2017. doi: 10.1007/s13300-021-01096-w

Table 2.

Coefficients of the Ochsner models for calculating 5-year risk of CHD, HF and stroke

CHD HF Stroke
Demographics
 Age, years 0.02143 0.03372 0.01705
 BMI, kg/m2 − 0.00959 0.01053 − 0.02817
 Sex
  Man 0.13083
 Race
  Black 0.22707 0.29277 0.03210
  Asian − 0.70858 − 0.91104 − 0.21774
  Other − 0.87601 − 0.06151
 Clinical or biomarkers
  Systolic blood pressure, mmHg 0.00213 0.00455 0.00990
  HbA1C, % 0.05607 0.03734 0.09647
  LDL cholesterol, mg/dl − 0.00078 − 0.00374
  HDL cholesterol, mg/dl − 0.00847
  Triglycerides, mg/dl 0.00067
  Estimated GFR, ml/min/1.73 m2 0.00292 − 0.00108 0.00111
 Medical history
  Hypertension history 0.55760 0.59334 0.23297
  CHD history 1.84915 0.37780 0.36549
  Heart failure history 0.46568 1.88251 0.58397
  Stroke history − 0.14675 0.18941 0.65132
 Medication prescription history
  Hypolipidemic drugs 0.34079
  Antidiabetic drugs 0.05846
  Antihypertensive drugs − 0.20982 − 0.17883

All risk factors listed in Table 1 were considered for inclusion; the ones listed in Table 2 were also selected for inclusion. The 5-year risk of an outcome can be computed as 1 – S0êβ×x-β×x¯. Here β is the coefficient, and x is the covariate vector for an individual patient within the Ochsner cohort. S0 for the CHD, HF and stroke are 0.898, 0.928 and 0.975, respectively. For example, a 65-year-old white man with BMI 34.9 kg/m2, systolic blood pressure 143 mmHg, HbA1c 8.4%, LDL cholesterol 110 mg/dl, HDL cholesterol 45 mg/dl, triglycerides 145 mg/dl and estimated GFR 52 ml/min/1.73 m2 and with hypertension history, without CHD/HF/stroke history, and currently using antidiabetic and antihypertensive drugs, would have a 5-year CHD risk of 1 − 0.898^exp (0.02143 × 65 − 0.00959 × 34.9 + 0.13083 × 1 + 0.00213 × 143 + 0.05607 × 8.4 − 0.00078 × 110 − 0.00847 × 45 + 0.00292 × 52 + 0.55760 × 1 + 0.05846 × 1 − 0.20982 × 1 − 1.37) = 0.192 or 19.2% 5-year risk, where 1.37 is the mean β×x¯)

CHD coronary heart disease; HF heart failure; BMI body mass index; LDL low-density lipoprotein; HDL high-density lipoprotein; GFR glomerular filtration rate